RARA and acute promyelocytic leukemia: The present study aimed to explore the role of AXL-RTK as a potential therapeutic target in PML/RARα-positive APL, its role in developing resistance to current therapeutics and the mechanism underlying resistance and inhibition of proliferation in APL.